Literature DB >> 10852115

Allograft rejection results from a failed attempt by the immune system to protect foreign tissue.

D S Hall1, E Roberts, J Davies.   

Abstract

The focus of our research is to understand the immune response to foreign tissue. We believe that a dichotomy exists within the immune response to an allograft such that part of the response is dedicated to the protection of the graft. Nevertheless, in a dominantly graft-aggressive environment, rejection typically ensues. In this article, we describe models that have been set up to test directly the ability of potentially protective aspects of the immune response to prevent allograft rejection. We discuss our data in the context of a growing body of exciting and often controversial literature.

Mesh:

Year:  2000        PMID: 10852115     DOI: 10.1385/ir:21:2-3:177

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  32 in total

1.  Human TH1 and TH2 subsets: doubt no more.

Authors:  S Romagnani
Journal:  Immunol Today       Date:  1991-08

2.  Transfusion of polarized TH2-like cell populations into SCID mouse cardiac allograft recipients results in acute allograft rejection.

Authors:  A M VanBuskirk; M E Wakely; C G Orosz
Journal:  Transplantation       Date:  1996-07-27       Impact factor: 4.939

3.  Unmodified pancreatic islet allograft rejection results in the preferential expression of certain T cell activation transcripts.

Authors:  P J O'Connell; A Pacheco-Silva; P W Nickerson; R A Muggia; M Bastos; V R Kelley; T B Strom
Journal:  J Immunol       Date:  1993-02-01       Impact factor: 5.422

4.  IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity.

Authors:  J R Piccotti; S Y Chan; R E Goodman; J Magram; E J Eichwald; D K Bishop
Journal:  J Immunol       Date:  1996-09-01       Impact factor: 5.422

5.  Delayed allograft rejection in mice transgenic for a soluble form of the IL-4 receptor.

Authors:  C R Maliszewski; P J Morrissey; W C Fanslow; T A Sato; C Willis; B Davison
Journal:  Cell Immunol       Date:  1992-09       Impact factor: 4.868

6.  Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells.

Authors:  F Powrie; M W Leach; S Mauze; S Menon; L B Caddle; R L Coffman
Journal:  Immunity       Date:  1994-10       Impact factor: 31.745

7.  Peripheral tolerance of an allograft in adult rats--characterization by low interleukin-2 and interferon-gamma mRNA levels and by strong accumulation of major histocompatibility complex transcripts in the graft.

Authors:  L Bugeon; M C Cuturi; M M Hallet; J Paineau; D Chabannes; J P Soulillou
Journal:  Transplantation       Date:  1992-08       Impact factor: 4.939

8.  Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming.

Authors:  R A Seder; R Gazzinelli; A Sher; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

9.  Regulation of alloreactivity in vivo by IL-4 and the soluble IL-4 receptor.

Authors:  W C Fanslow; K N Clifford; L S Park; A S Rubin; R F Voice; M P Beckmann; M B Widmer
Journal:  J Immunol       Date:  1991-07-15       Impact factor: 5.422

10.  Regulatory T cells in the control of autoimmunity: the essential role of transforming growth factor beta and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4(+)CD45RC- cells and CD4(+)CD8(-) thymocytes.

Authors:  B Seddon; D Mason
Journal:  J Exp Med       Date:  1999-01-18       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.